Peer-influenced content. Sources you trust. No registration required. This is HCN.
Cleveland Clinic Journal of Medicine
Despite its theoretical benefits, IV albumin has not shown consistent superiority over crystalloid solutions in sepsis management, prompting a reevaluation of fluid resuscitation strategies in critical care settings.
Emergency Medicine July 16th 2024
Medical Xpress
Incidence rates provide a truer measure of medication-induced liver injury, revealing misclassifications in traditional methods. This study highlights the need for closer monitoring of certain medications using real-world healthcare data.
Hepatology July 2nd 2024
Pain Medicine News
Integrating telehealth into opioid treatment programs drastically improves hepatitis C cure rates, particularly among underserved populations, by facilitating seamless access to DAAs and continuous follow-up care.
Hepatology June 24th 2024
The New England Journal of Medicine
A phase 2 trial found that tirzepatide, administered once weekly, significantly improved the resolution of MASH and fibrosis stages in patients with moderate to severe liver fibrosis. These results highlight tirzepatide’s potential as a treatment option, emphasizing the need for further research to validate these findings in larger, long-term studies.
Hepatology June 20th 2024
Cardiac complications significantly influence the success of liver transplants. Effective preoperative cardiac risk stratification and careful intraoperative management are essential to optimize patient outcomes.
Cardiology May 16th 2024
The Epoch Times
Understanding liver cancer’s complexities is crucial in guiding patients towards effective treatment and preventive measures. This overview sheds light on the pivotal aspects of managing liver cancer, from symptoms to therapy options.
Hepatology April 29th 2024